Pöördumine

Saatja: "Giga, Lelde" <[email protected]> Saaja: [email protected] Teema: FW: HTA Regulation No. 2021/2282 Kuupäev: 2024-11-26 11:16 Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Hi, I wanted to ask if you could help me understand the planned measures related to Regulation No. 2021/2282 in Estonia. Are there any planned changes in relation to this EU regulation on HTA and in which Estonian regulatory acts? Also, has there been or will there be any event explaining these changes? Thank you very much in advance! Best regards Lelde Ģiga Market Access and Governmental Affairs Manager Baltics Medtronic Baltic Representative Office M. Nometnu 31-311 | Riga, LV-1002 | Latvia Mobile &#43;371 28710644 [email protected] medtronic.com | Facebook | LinkedIn | Twitter | YouTube <https://www.medtronic.com/us-en/index.html> [CONFIDENTIALITY AND PRIVACY NOTICE] Information transmitted by this email is proprietary to Medtronic and is intended for use only by the individual or entity to which it is addressed, and may contain information that is private, privileged, confidential or exempt from disclosure under applicable law. If you are not the intended recipient or it appears that this mail has been forwarded to you without proper authority, you are notified that any use or dissemination of this information in any manner is strictly prohibited. In such cases, please delete this mail from your records. To view this notice in other languages you can either select the following link or manually copy and paste the link into the address bar of a web browser: http://emaildisclaimer.medtronic.com